In breast cancer, miRNA expression profiling using microarray technology in association with some biopathological features such as estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) status has been established as a useful tool to classify tumors [12], [13], [14], [15]. Here, ESR1 is linked to breast carcinoma.